Skip to main content
Feedback to SSRN
Feedback
(required)
Email
(required)
Submit
Yanqiao Zhang
Harbin Medical University - Cancer Hospital
China
Learn more about SSRN Profiles
SCHOLARLY PAPERS
1
DOWNLOADS
181
TOTAL CITATIONS
2
Feedback
Scholarly Papers (1)
Sort by:
Paper Title, A-Z
Paper Title, Z-A
Author Name, A-Z
Author Name, Z-A
Date Posted, Ascending
Date Posted, Descending
Downloads, Ascending
Downloads, Descending
Citations, Ascending
Citations, Descending
Actions:
Email selected abstracts
View:
Selected
Original List
All Versions
Hide All Versions
All Abstracts
Hide All Abstracts
(Rank)
1.
Safety, Efficacy and Biomarkers of Toripalimab in Patients with Recurrent or Metastatic Neuroendocrine Neoplasms: A Multiple-Center Phase Ib Trial
Number of pages: 139
Posted: 26 Nov 2019
Ming Lu
,
Panpan Zhang
, Yanqiao Zhang,
Zhongwu Li
,
Jifang Gong
,
Jie Li
,
Jian Li
,
Yan Li
,
Xiaotian Zhang
,
Zhihao Lu
,
Xicheng Wang
,
Jun Zhou
,
Zhi Peng
,
Weifeng Wang
,
Hui Feng
,
Hai Wu
,
Sheng Yao
and
Lin Shen
Peking University - Key Laboratory of Carcinogenesis and Translational Research, Peking University - Key Laboratory of Carcinogenesis and Translational Research, Harbin Medical University - Cancer Hospital, Peking University - Key Laboratory of Carcinogenesis and Translational Research, Peking University - Key Laboratory of Carcinogenesis and Translational Research, Peking University - Key Laboratory of Carcinogenesis and Translational Research, Peking University - Key Laboratory of Carcinogenesis and Translational Research, Peking University - Key Laboratory of Carcinogenesis and Translational Research, Peking University - Key Laboratory of Carcinogenesis and Translational Research, Peking University - Key Laboratory of Carcinogenesis and Translational Research, Peking University - Key Laboratory of Carcinogenesis and Translational Research, Peking University - Key Laboratory of Carcinogenesis and Translational Research, Peking University - Key Laboratory of Carcinogenesis and Translational Research, OrigiMed, Inc., Shanghai Junshi Biosciences Co., LTD, Shanghai Junshi Biosciences Co., LTD, Shanghai Junshi Biosciences Co., LTD and Peking University - Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing)
Downloads
181
(418,025)
Citation
2
View PDF
Download
Abstract:
Neuroendocrine neoplasm, NET, NEC, PD-1,toripalimab
Feedback